10X GENOMICS INC
10X GENOMICS INC
Share · US88025U1097 · TXG · A2PPQJ (XNAS)
Overview
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
11
9
1
0
No Price
31.10.2025 08:57
Current Prices from 10X GENOMICS INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
TXG
USD
31.10.2025 08:57
12,51 USD
0,07 USD
+0,56 %
Share Float & Liquidity
Free Float 87,83 %
Shares Float 109,33 M
Shares Outstanding 124,48 M
Invested Funds

The following funds have invested in 10X GENOMICS INC:

Fund
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)
Vol. in million
26,43
Percentage (%)
0,20 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
632,22
Percentage (%)
0,17 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. in million
61,33
Percentage (%)
0,06 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. in million
1,60
Percentage (%)
0,06 %
Fund
iShares MSCI USA Momentum Factor ESG UCITS ETF USD (Acc)
Vol. in million
929,27
Percentage (%)
0,06 %
Company Profile for 10X GENOMICS INC Share
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Get up to date insights from finAgent about 10X GENOMICS INC

Company Data

Name 10X GENOMICS INC
Company 10x Genomics, Inc.
Symbol TXG
Website https://www.10xgenomics.com
Primary Exchange XNAS NASDAQ
WKN A2PPQJ
ISIN US88025U1097
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Serge Saxonov
Market Capitalization 2 Mrd.
Country United States of America
Currency USD
Employees 1,3 T
Address 6230 Stoneridge Mall Road, 94588-3260 Pleasanton
IPO Date 2019-09-12

Stock Splits

Date Split
17.07.2006 1:2

Ticker Symbols

Name Symbol
Frankfurt 1KJ.F
NASDAQ TXG
More Shares
Investors who hold 10X GENOMICS INC also have the following shares in their portfolio:
DT.BANK MTN 15/35
DT.BANK MTN 15/35 Bond
Greenway Technology
Greenway Technology Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025